<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PRF</journal-id>
<journal-id journal-id-type="hwp">spprf</journal-id>
<journal-id journal-id-type="nlm-ta">Perfusion</journal-id>
<journal-title>Perfusion</journal-title>
<issn pub-type="ppub">0267-6591</issn>
<issn pub-type="epub">1477-111X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0267659111433098</article-id>
<article-id pub-id-type="publisher-id">10.1177_0267659111433098</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial</article-title>
</title-group>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>1</issue>
<fpage>5</fpage>
<lpage>6</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2011</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>At the recent Perfusion Editorial Board meeting held during the European Association of Cardiothoracic Surgery annual meeting in Lisbon, the unambiguous euphoric feeling of the Board was supported by data confirming an increase in the number and scientific content of submitted manuscripts, leading to an increase of fifty per cent more submissions and an increase in the impact factor to 0.745. Similar trends are also apparent as we usher in 2012.</p>
<p>A positive momentum shift, supported by increasingly credible perfusion research, superb presentations, and new technology, seems to be focusing on driving our specialty forward rather than merely protecting what we have had in the past.</p>
<p>This issue of the journal is a prime example of all the aforementioned points: fourteen quality articles covering case studies, pharmacotherapeutics, long-term support, biocompatibility, basic science, inflammatory response, coagulation, and paediatrics. This is an excellent cross-section of the key components or ‘key parts’ underpinning artificial heart and lung support.</p>
<p>Papers from Iritakenishi <italic>et al</italic>.<sup><xref ref-type="bibr" rid="bibr1-0267659111433098">1</xref></sup> and Itoh, <italic>et al</italic>.<sup><xref ref-type="bibr" rid="bibr2-0267659111433098">2</xref></sup> describe the effects of milrinone on cerebral oxygen balance and the results of a practice survey across 52 paediatric centres, respectively. Both these papers, originating from Japan, extol the virtue of sharing experience, another ‘key part’ of our speciality that we cannot underestimate and must embrace.</p>
<p>I was privileged to attend the recent Japanese Society of Extracorporeal Technology (JaSECT) annual meeting held in Nagoya. I was inspired by presentations involving local experience and examples of disposables and hardware being used in different innovative ways than in other parts of the World. Japan, although smaller than the state of California, boasts approximately five hundred centres performing cardiac surgery. This local diversity sparked valuable debate and significantly expanded my thinking in terms of innovation and research.</p>
<p>The ‘key parts’ that I refer to, do not just involve which techniques and equipment we use, or indeed their clinical impact. Sharing this local experience, no matter how routine the perfusionists or cardiac teams involved feel their practice is, will help educate and improve practices worldwide. A modern definitive journal, <italic>Perfusion</italic> is the ideal medium to disseminate this shared knowledge.</p>
<p>All of these independent ‘key parts’ and, in terms of this issue, the independent papers, are intrinsically linked. The links are inescapable. Greiner <italic>et al</italic>.<sup><xref ref-type="bibr" rid="bibr3-0267659111433098">3</xref></sup> discussing DEHP, its active metabolites and the absence of their effect on the inflammatory response highlights the balance that needs to be evaluated alongside the increased surface areas and types of material used to realise the clinical benefits of zero balance ultrafiltration described by Mick <italic>et al</italic>.<sup><xref ref-type="bibr" rid="bibr4-0267659111433098">4</xref></sup> Litmathe <italic>et al</italic>.<sup><xref ref-type="bibr" rid="bibr5-0267659111433098">5</xref></sup> and Griffith <italic>et al</italic>.<sup><xref ref-type="bibr" rid="bibr6-0267659111433098">6</xref></sup> present data on two different aspects of long-term support and both will recognise, as we all do, the importance of understanding S-100 Beta protein and interferon gamma receptor expression presented by Bayram <italic>et al</italic>.<sup><xref ref-type="bibr" rid="bibr7-0267659111433098">7</xref></sup> and Jankovicova <italic>et al</italic>.,<sup><xref ref-type="bibr" rid="bibr8-0267659111433098">8</xref></sup> respectively. Their consequence in short-term support has significant implications in the long-term support environment.</p>
<p>Melchior <italic>et al</italic>.<sup><xref ref-type="bibr" rid="bibr9-0267659111433098">9</xref></sup> highlight the importance of the communication skills, vital not only during conventional cardiopulmonary bypass, but even more so with use of miniature bypass technology. Therefore, this paper from Melchior and co-workers holds an interrelated message not only for cardiac teams learning from the work presented in this issue by Haneya <italic>et al</italic>.<sup><xref ref-type="bibr" rid="bibr10-0267659111433098">10</xref></sup> using miniature technology as a bridge to long-term support, but also for those readers keen to realise the reduction in red blood cell damage and benefits of reduced transfusion requirements demonstrated by Lui <italic>et al</italic>.<sup><xref ref-type="bibr" rid="bibr11-0267659111433098">11</xref></sup> in their submission on MECC.</p>
<p>Given the evolution of our patient population, cardiac surgery, and perfusion, it is very unlikely that one of these ‘key parts’ will revolutionise our speciality on its own. The intrinsic link between these parts is, as we know, not new. Aristotle, the famous Greek philosopher, would most likely have made an excellent perfusionist given his commentary and understanding on both the physical sciences (non-living science) and life sciences.</p>
<p>Perfusion bridges these two sciences on a daily basis, and it becomes clear as we move forward that Aristotle makes a very valid and modern perfusion point:</p>
<p><disp-quote>
<p><italic>‘The whole is greater than the sum of its parts’, Aristotle (384 BC-322 BC)</italic></p>
</disp-quote></p>
<sig-block>
<sig>John Mulholland<break/>
<italic>Section Editor</italic></sig>
</sig-block>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-0267659111433098">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Iritakenishi</surname><given-names>T</given-names></name>
<name><surname>Hayashi</surname><given-names>Y</given-names></name>
<name><surname>Yamanaka</surname><given-names>H</given-names></name>
<name><surname>Kamibayashi</surname><given-names>T</given-names></name>
<name><surname>Ueda</surname><given-names>K</given-names></name>
<name><surname>Mashimo</surname><given-names>T</given-names></name>
</person-group>. <article-title>Milrinone, a phosphodiesterase III inhibitor, prevents reduction of jugular bulb saturation during rewarming from hypothermic cardiopulmonary bypass</article-title>. <source>Perfusion</source> <year>2012</year>; <volume>27</volume>(<issue>1</issue>): <fpage>13</fpage>–<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr2-0267659111433098">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Itoh</surname><given-names>H</given-names></name>
<name><surname>Sano</surname><given-names>S</given-names></name>
<name><surname>Pouard</surname><given-names>P</given-names></name>
</person-group>. <article-title>Pediatric perfusion in Japan: 2010 practice survey</article-title>. <source>Perfusion</source> <year>2012</year>; <volume>27</volume>(<issue>1</issue>): <fpage>72</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr3-0267659111433098">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Greiner</surname><given-names>TO</given-names></name>
<name><surname>Volkmann</surname><given-names>AS</given-names></name>
<name><surname>Hildenbrand</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>DEHP and its active metabolites: leaching from different tubing types, impact on proinflammatory cytokines and adhesion molecule expression. Is there a subsumable context?</article-title> <source>Perfusion</source> <year>2012</year>; <volume>27</volume>(<issue>1</issue>): <fpage>21</fpage>–<lpage>29</lpage>.</citation>
</ref>
<ref id="bibr4-0267659111433098">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mick</surname><given-names>S</given-names></name>
<name><surname>Hilberath</surname><given-names>JN</given-names></name>
<name><surname>Davidson</surname><given-names>MJ</given-names></name>
<name><surname>FitzGerald</surname><given-names>D</given-names></name>
</person-group>. <article-title>Zero balance ultrafiltration for the correction of acute acidosis after a period of prolonged deep hypothermic circulatory arrest</article-title>. <source>Perfusion</source> <year>2012</year>; <volume>27</volume>(<issue>1</issue>): <fpage>9</fpage>–<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr5-0267659111433098">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Litmathe</surname><given-names>J</given-names></name>
<name><surname>Sucker</surname><given-names>C</given-names></name>
<name><surname>Easo</surname><given-names>J</given-names></name>
<name><surname>Wigger</surname><given-names>L</given-names></name>
<name><surname>Dapunt</surname><given-names>O</given-names></name>
</person-group>. <article-title>Prone and ECMO – a contradiction per se?</article-title> <source>Perfusion</source> <year>2012</year>; <volume>27</volume>(<issue>1</issue>): <fpage>78</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr6-0267659111433098">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Griffith</surname><given-names>KE</given-names></name>
<name><surname>Jenkins</surname><given-names>1E</given-names></name>
<name><surname>Stulak</surname><given-names>J</given-names></name>
<name><surname>Paugh</surname><given-names>T</given-names></name>
<name><surname>Pagani</surname><given-names>FD</given-names></name>
</person-group>. <article-title>Long-term use of the CentriMag<sup>®</sup> Ventricular Assist System as a right ventricular assist device: a case report</article-title>. <source>Perfusion</source> <year>2012</year>; <volume>27</volume>(<issue>1</issue>): <fpage>65</fpage>–<lpage>70</lpage>.</citation>
</ref>
<ref id="bibr7-0267659111433098">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bayram</surname><given-names>H</given-names></name>
<name><surname>Erer</surname><given-names>D</given-names></name>
<name><surname>Iriz</surname><given-names>E</given-names></name>
<name><surname>Zor</surname><given-names>MH</given-names></name>
<name><surname>Gulbahar</surname><given-names>O</given-names></name>
<name><surname>Ozdogan</surname><given-names>ME</given-names></name>
</person-group>. <article-title>Comparison of the effects of pulsatile cardiopulmonary bypass, non-pulsatile cardiopulmonary bypass and off-pump coronary artery bypass grafting on the inflammatory response and S-100beta protein</article-title>. <source>Perfusion</source> <year>2012</year>; <volume>27</volume>(<issue>1</issue>): <fpage>56</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr8-0267659111433098">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jankovicova</surname><given-names>K</given-names></name>
<name><surname>Kolackova</surname><given-names>M</given-names></name>
<name><surname>Kunes</surname><given-names>P</given-names></name>
<name><surname>Holubcova</surname><given-names>Z</given-names></name>
<name><surname>Krejsek</surname><given-names>J</given-names></name>
<name><surname>Mandak</surname><given-names>J</given-names></name>
</person-group>. <article-title>Interferon gamma receptor expression on granulocytes of cardiac surgical patients is modulated differently by the type of cardiopulmonary bypass used</article-title>. <source>Perfusion</source> <year>2012</year>; <volume>27</volume>(<issue>1</issue>): <fpage>49</fpage>–<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr9-0267659111433098">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Melchior</surname><given-names>RW</given-names></name>
<name><surname>Rosenthal</surname><given-names>T</given-names></name>
<name><surname>Schiavo</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>A systematic evaluation of the core communication skills expected of a perfusionist</article-title>. <source>Perfusion</source> <year>2012</year>; <volume>27</volume>(<issue>1</issue>): <fpage>43</fpage>–<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr10-0267659111433098">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Haneya</surname><given-names>A</given-names></name>
<name><surname>Philipp</surname><given-names>A</given-names></name>
<name><surname>Puehler</surname><given-names>T</given-names></name>
<etal/>
</person-group>. <article-title>Successful use of a percutaneous miniaturized extracorporeal life support system as a bridge and assistance to left ventricular assist device implantation in a patient with severe refractory cardiogenic shock</article-title>. <source>Perfusion</source> <year>2012</year>; <volume>27</volume>(<issue>1</issue>): <fpage>18</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr11-0267659111433098">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Y</given-names></name>
<name><surname>Tao</surname><given-names>L</given-names></name>
<name><surname>Wang</surname><given-names>X</given-names></name>
<name><surname>Cui</surname><given-names>H</given-names></name>
<name><surname>Chen</surname><given-names>X</given-names></name>
<name><surname>Ji</surname><given-names>B</given-names></name>
</person-group>. <article-title>Beneficial effects of using a minimal extracorporeal circulation system during coronary artery bypass grafting</article-title>. <source>Perfusion</source> <year>2012</year>; <volume>27</volume>(<issue>1</issue>): <fpage>83</fpage>–<lpage>89</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>